Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01050143 | tetranor 12 HETE | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 11.6 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 14.2 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 13.5 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 13.1 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 10.6 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 8.7 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 5.47 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 2.99 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | C | 0.0 | BCD100322A01 | 11.3 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | C | 0.5 | BCD100322A03 | 15.1 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | C | 1.0 | BCD100322A07 | 14.4 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | C | 2.0 | BCD100322A11 | 13 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | C | 4.0 | BCD100322A15 | 14.4 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | C | 8.0 | BCD100322A19 | 10.9 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | C | 12.0 | BCD100322A23 | 9.45 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | C | 24.0 | BCD100322A27 | 6.06 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 12.9 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 15 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 10.4 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 10.5 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 8.81 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 4.74 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 3.3 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol | 0.5 | BCD100322A04 | 14.2 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol | 1.0 | BCD100322A08 | 14.8 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol | 2.0 | BCD100322A12 | 13.9 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol | 4.0 | BCD100322A16 | 13.5 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol | 8.0 | BCD100322A20 | 10.1 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol | 12.0 | BCD100322A24 | 7.02 | pmol/sample |
| LMFA01050143 | tetranor 12 HETE | 25OH-Chol | 24.0 | BCD100322A28 | 3.86 | pmol/sample |